Q2 2026 Earnings Call August 20, 2026 9:00 AM EDTCompany ParticipantsSrishti Gupta - CEO & DirectorKyler Lei - ...
Operator: Good day, and thank you for standing by. Welcome to the Moderna Second Quarter 2026 Conference Call. Please be ...
Heightened clinical activity and pipeline advancement highlighted by Quince Therapeutics’ Phase 3 NEAT trial evaluation of eDSP, IntraBio’s Fast Track development of IB1001, Acasti Pharma’s ...
Objectives To estimate the item-level conditional association network of depression, anxiety and stress symptoms in patients with non-Hodgkin’s lymphoma (NHL) during a prespecified chemotherapy ...
Smart digital health has reshaped patient monitoring, but it faces a fundamental trade-off between device intelligence and continuous, energy-efficient monitoring. Inspired by self-sustaining ...
A configurable bioengineered multitissue platform with vascular circulation enables investigation of human breast cancer ...
Strong unitary designs, essential for quantum scrambling and algorithm development, can now be generated in optimal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results